EyeBio is a newly launched global company developing the next generation of eye disease therapies
Founded by two pioneers in ophthalmology drug development to build and advance diversified pipeline of ocular therapies
Jeito selects EyeBio as its 8th investment and continues to build a strong & diversified portfolio of companies with groundbreaking therapies in areas of high unmet need
Location: United Kingdom, England, London
Total raised: $195M
Investors 3
| Date | Name | Website |
| 27.02.2022 | Jeito Capi... | jeito.life |
| 10.03.2024 | Omega Fund... | omegafunds... |
| 07.09.2022 | MRL Ventur... | mrlv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.11.2023 | - | $130M | - |
| 23.02.2022 | Series A | $65M | Jeito Capi... |
Mentions in press and media 8
| Date | Title | Description | Source |
| 14.11.2023 | EyeBio Announces Expansion of Series A to $130 Million, Adva... | EyeBio doubles the size of its original Series A raise with an additional $65 million, with new inve... | svhealthin... |
| 14.11.2023 | EyeBio Expands Series A to $130M | EyeBiotech, a London, UK-based clinical-stage ophthalmology biotechnology company, raised additional... | finsmes.co... |
| 14.06.2023 | EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of... | AMARONE (Anti-permeability Mechanism and Age-Related Ocular Neovascularization Evaluation) is first ... | svhealthin... |
| 06.03.2023 | EyeBio Announces First Asset in Innovative Pipeline of Retin... | Additions to EyeBio’s leadership team include world-class disrupters with deep experience addressing... | svhealthin... |
| 22.02.2022 | Biotech startup EyeBio closes $65M to develop a new generati... | It’s the 21st century, and there are still millions of people suffering from some forms of eye disor... | techstartu... |
| 22.02.2022 | EyeBio Raises $65M in Series A Funding to Develop New Genera... | Leaders in ophthalmology drug development launch new global company to build and advance diversified... | svhealthin... |
| 22.02.2022 | EyeBiotech Raises $65M in Series A Funding | EyeBiotech Limited, a London, UK-based held ophthalmology biotechnology company, raised $65M in Seri... | finsmes.co... |
| - | Eyebiotech | “Developing a new generation of therapies to protect, restore, and improve vision” | fastfounde... |